Table 3 Clinical characteristics of HIV- positive women on ART follow-up in Nekemte town public health facilities, Western Ethiopia, from March-April, 2020
Characteristics N = 420 | Frequency | Percent (%) |
|---|---|---|
Viral loud | ||
<=1000 copies/ml | 359 | 85.48 |
> 1000 copies/ml | 61 | 14.52 |
CD4 count | ||
< 200cells/mm3 | 26 | 6.19 |
200-350cells/mm3 | 30 | 7.14 |
351-500cells/mm3 | 58 | 13.81 |
> 500cells/mm3 | 306 | 72.86 |
Presence of OI | ||
Yes | 82 | 19.52 |
No | 338 | 80.48 |
HIV/AIDS clinical stage | ||
I | 245 | 58.33 |
II | 100 | 23.81 |
III | 62 | 14.76 |
IV | 13 | 3.10 |
Adherence to ART drug | ||
Less than or equal to two times/month | 372 | 88.57 |
From 3–5 times/month | 25 | 5.95 |
More than or equal to 6 times/ month | 23 | 5.48 |
Partner HIV status | ||
Positive | 282 | 67.14 |
Negative | 108 | 25.71 |
Un known | 30 | 7.14 |
Result disclosure to husband | ||
Yes | 369 | 87.86 |
No | 51 | 12.14 |
Relationship of the family after result disclosure | ||
Better | 107 | 25.48 |
Worse | 109 | 25.95 |
no change | 204 | 48.57 |
Result Disclosure other than Partner | ||
Yes | 310 | 73.81 |
No | 110 | 26.19 |
Support received after disclosure other than the partner | ||
Nothing | 117 | 27.86 |
Advice | 201 | 47.86 |
Money | 102 | 24.29 |